The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackstone Loan Regulatory News (BGLF)

Share Price Information for Blackstone Loan (BGLF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.59
Bid: 0.57
Ask: 0.61
Change: 0.00 (0.00%)
Spread: 0.04 (7.018%)
Open: 0.59
High: 0.59
Low: 0.59
Prev. Close: 0.59
BGLF Live PriceLast checked at -
Blackstone/GSO Loan Financing is an Investment Trust

To provide shareholders with stable and growing income returns, and to grow the capital value of the investment portfolio by exposure to all debt tranches of CLOs (CLO Income Notes and other CLO Securities) and in Loan Warehouses.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Managed Wind-Down of the Company

23 Jun 2023 18:09

RNS Number : 8034D
Blackstone Loan Financing Limited
23 June 2023
 

The information contained within this announcement constitutes inside information.

 

23 June 2023

 

Blackstone Loan Financing Limited

 

(the "Company")

 

Proposed Managed Wind-Down of the Company

 

Blackstone Loan Financing Limited announces that after extensive consultation with its advisers, the board of directors (the "Board") has decided to put forward proposals for a managed wind-down of the Company (the "Managed Wind-Down"). The Board and Blackstone Ireland Limited (the "Investment Adviser") unanimously recommend that shareholders vote in favour of the Managed Wind-Down of the Company, which they believe to be in the best interest of shareholders, for the reasons set out below.

The performance of the Company has proved resilient over its nine-year life, which has spanned a variety of market conditions. Its strong performance has been supported by its underlying investments, which have provided shareholders with uninterrupted cashflows and high current income, despite many periods of volatility.

However, in reaching this decision, the Board took into account a number of factors, including the prevailing discount to net asset value at which the shares have been trading, the market capitalisation and liquidity of the shares, and the Company's structure. Furthermore, it was recognised that while the Company's share price continues to trade at a discount to net asset value, it is limited in its reinvestment opportunities and ability to grow through further share issuance. The Board therefore believes that an orderly realisation of the Company's investments will be in the best interest of shareholders as a whole. 

Approval of the wind down will not result in an immediate liquidation of the Company, rather an orderly realisation of the Company's underlying assets in a manner consistent with regulatory risk retention requirements and other contractual restrictions on the liquidity of the Company's portfolio. Capital will be returned to shareholders as the Company's underlying CLOs are matured or redeemed and in a manner that seeks to maximise shareholder value. The Board intends to maintain the Company's listing during the realisation period. The Board intends to maintain its current target level of dividend until the commencement of the orderly realisation.

Accordingly, the Board intends to publish a shareholder circular by the end of September 2023 (the "Circular") to convene an extraordinary general meeting (the "EGM") at which it will seek approval from shareholders for the Managed Wind-Down and any related matters required to facilitate an orderly realisation.

 

The person responsible for arranging for the release of this announcement on behalf of the Company is Priya Mooroogen of BNP Paribas S.A., Jersey Branch, Company Secretary.

 

Enquiries:

 

Blackstone Loan Financing Limited via BNP Paribas

Charlotte Valeur, Chair

 

BNP Paribas 01534 709189 / 813967

 

Singer Capital Markets 020 7496 3000

James Maxwell / Alaina Wong (Corporate Finance)

Alan Geeves / Sam Greatrex (Sales)

 

Winterflood Investment Trusts 020 3100 0000

Neil Langford (Corporate Finance)

Darren Willis (Sales)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFJMRTMTMTBIJ
Date   Source Headline
22nd Apr 20247:00 amRNSDividend Declaration
22nd Apr 20247:00 amRNSNet Asset Value and Publication of Monthly Report
19th Apr 202412:31 pmRNSDirector Declaration
22nd Mar 20247:00 amRNSNet Asset Value and Publication of Monthly Report
23rd Feb 20244:44 pmRNSDIVIDEND CURRENCY ELECTION
22nd Feb 20247:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
23rd Jan 20247:00 amRNSDividend Declaration
22nd Jan 20245:05 pmRNSNet Asset Value and Publication of Monthly Report
22nd Dec 20237:00 amRNSCancellation of Treasury Shares
21st Dec 20234:13 pmRNSIssuance of Deferred Share
21st Dec 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
21st Nov 20231:17 pmRNSDIVIDEND CURRENCY ELECTION
21st Nov 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
13th Nov 20234:20 pmRNSQ3 2023 Report and Investor Call
20th Oct 20237:00 amRNSNet Asset Value(s)
20th Oct 20237:00 amRNSDividend Declaration
26th Sep 20237:00 amRNSHalf-year Report
21st Sep 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
15th Sep 20231:21 pmRNSResult of Extraordinary General Meeting
25th Aug 20237:00 amRNSNotice of Extraordinary General Meeting
24th Aug 20234:07 pmRNSDirectorate Change
22nd Aug 20237:00 amRNSNet Asset Value and Publication of Monthly Report
9th Aug 20233:56 pmRNSQ2 2023 Report and Investor Call
26th Jul 20234:29 pmRNSBoard Update
26th Jul 20234:29 pmRNSResult of AGM
21st Jul 20237:00 amRNSDividend Declaration
21st Jul 20237:00 amRNSNet Asset Value and Publication of Monthly Report
10th Jul 20235:21 pmRNSNotice of Annual General Meeting
23rd Jun 20236:09 pmRNSProposed Managed Wind-Down of the Company
22nd Jun 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
23rd May 20237:00 amRNSNet Asset Value and Publication of Monthly Report
11th May 20236:04 pmRNSQ1 2023 Report and Investor Call
28th Apr 20237:00 amRNSAnnual Financial Report
25th Apr 20237:00 amRNSDividend Declaration
25th Apr 20237:00 amRNSNet Asset Value(s)
3rd Apr 20234:54 pmRNSTotal Voting Rights
3rd Apr 20237:00 amRNSDirectorate Change
22nd Mar 20237:00 amRNSNet Asset Value(s)
17th Mar 20237:00 amRNSResults of Shareholder Consultation
2nd Mar 20235:31 pmRNSTransaction in Own Shares
2nd Mar 20235:08 pmRNSTransaction in Own Shares
1st Mar 20235:11 pmRNSTransaction in Own Shares
1st Mar 20233:05 pmRNSTotal Voting Rights
24th Feb 20234:18 pmRNSDIVIDEND CURRENCY ELECTION
22nd Feb 20237:00 amRNSNet Asset Value and Publication of Monthly Report
10th Feb 20234:48 pmRNSTransaction in Own Shares
10th Feb 20234:12 pmRNSNon-material change to Investment Policy
10th Feb 20231:58 pmRNSQ4 2022 Report and Investor Call
1st Feb 20233:36 pmRNSHolding(s) in Company
1st Feb 20231:10 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.